Selective blood-brain barrier permeabilization of brain metastases by a type 1 receptor-selective tumor necrosis factor mutein
<p><strong>Background</strong></p> Metastasis to the brain is a major challenge with poor prognosis. The blood-brain barrier (BBB) is a significant impediment to effective treatment, being intact during the early stages of tumour development and heterogeneously permeable at l...
Main Authors: | Munoz Pinto, MF, Campbell, SJ, Simoglou Karali, C, Johanssen, VA, Bristow, C, Cheng, VWT, Zarghami, N, Larkin, JR, Pannell, M, Hearn, A, Chui, C, Brinquis Nunez, B, Bokma, E, Holgate, R, Anthony, DC, Sibson, NR |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2021
|
Similar Items
-
Selective permeabilization of the blood-brain barrier at sites of metastasis
by: Sibson, N, et al.
Published: (2013) -
A novel molecular magnetic resonance imaging agent targeting activated leukocyte cell adhesion molecule as demonstrated in mouse brain metastasis models
by: Zarghami, N, et al.
Published: (2020) -
The ambiguity of brain metastasis response to radiotherapy driven by cellular adhesion molecules
by: Soto, M, et al.
Published: (2017) -
Selective permeabilisation of the blood-brain barrier during brain metastasis via TNFR1
by: Karali, C
Published: (2018) -
A brain metastasis therapy tweak, for the better? Concomitant stereotactic radiotherapy and molecular-targeted therapy
by: Soto, M, et al.
Published: (2017)